Abstract:Objective To investigate the effects of puerarin combined with silver-hydroxyapatite (Ag-HA) coating implantation on inflammations, bone mineral density (BMD), and bone biological parameters in rats with peri-implantitis, and to provide new insights and experimental evidence for the treatment of peri-implantitis by comparing the clinical manifestations, gene and protein expression of inflammatory cytokines, and BMD across different treatment groups.Methods Fifty male rats were selected for this study and induced with peri-implantitis. After successful modeling, the rats were randomly divided into three groups: the peri-implantitis group (10 rats), the Ag-HA group (20 rats), and the combination group (20 rats). The peri-implantitis group received no intervention, the Ag-HA group was treated with Ag-HA coating implantation, and the combination group received both puerarin and Ag-HA coating implantation. The rats were evaluated preoperatively and at 1, 2, 4, and 8 weeks postoperatively for sulcus bleeding index (SBI), gingival index (GI), probing depth (PD), serum levels of inflammatory factors, and osseointegration capacity. Periodontal tissues were collected from all three groups of rats at 8 weeks postoperatively, and mRNA levels of relevant genes were detected using real-time quantitative PCR. Western blotting was performed to assess the expression of associated proteins. Micro-CT 3D reconstruction was carried out on the rat models, and bone biological parameters were statistically analyzed and compared.Results Comparisons were made on the SBI, GI, PD, levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-1β, and alkaline phosphatase (ALP), and the bone-implant contact rate among the three groups preoperatively and at 1, 2, 4, and 8 weeks postoperatively. The results exhibited that these indicators were statistically significant different across the time points (P < 0.05) and among the groups (P < 0.05), where the SBI, GI, PD, and levels of TNF-α, IL-6, and IL-1β were lower and the ALP level and the bone-implant contact rate were higher in the combination group, indicating better therapeutic outcomes. The change trends of all these indicators (P < 0.05) but ALP were significantly different among the groups (P > 0.05). The relative mRNA and protein expression levels of IL-1β, CXCL12, and CXCR4 in the periodontal tissues of rats in the combination group were lower than those in the Ag-HA group (P < 0.05), while the relative mRNA and protein expression levels of osteoprotegerin (OPG) in the combination group were higher than those in the Ag-HA group (P < 0.05). The tissue mineral density, bone volume-to-total volume ratio (BV/VT), and trabecular thickness (Tb.Th) of rats in the combination group were higher than those in the Ag-HA group (P < 0.05), whereas the BMD and distance from cementoenamel junction to alveolar bone crest (CEJ-ABC) were lower in the combination group than those in the Ag-HA group (P < 0.05).Conclusion Puerarin combined with Ag-HA coating implantation significantly improves inflammation levels, GI, PD, and osseointegration capacity in peri-implantitis rats. The combination treatment demonstrates more pronounced effects in suppressing inflammation, enhancing bone density, and promoting periodontal tissue repair compared to Ag-HA coating implantation alone. Notably, the combination therapy exhibits superior effects on OPG protein expression and bone biological parameters, suggesting their potential applicability in the treatment of peri-implantitis.